← Open Payments lookup

PAUL SHESLOW: Open Payments

NPI 1295201994 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$219 in 11 payments from 8 companies in 2025. Trend: 2023 $937 · 2024 $889 · 2025 $219

Food & beverage: $219
CompanyPaymentsAmount
Axsome Therapeutics, Inc.3$60
Lundbeck LLC2$34
Takeda Pharmaceuticals U.S.A., Inc.1$28
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24
Bausch Health US, LLC1$20
Neurocrine BioSciences, Inc.1$19
Alkermes, Inc.1$18
Supernus Pharmaceuticals, Inc.1$16

Products named: Auvelity, REXULTI, TRINTELLIX, CAPLYTA, APLENZIN, INGREZZA, LYBALVI, Qelbree.

Industry payments across DE — which companies pay providers there.